Azhar B. Ali

MD6, #12-01, 14 Medical Drive
Singapore, 117599, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Dual actionability of BMI1 activation and mitotic vulnerability defines adaptive Osimertinib resistance in EGFR-mutant NSCLC.

Dual actionability of BMI1 activation and mitotic vulnerability defines adaptive Osimertinib resistance in EGFR-mutant NSCLC.

Journal: Cell death & disease
Published: December 16, 2025

Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancers.

Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancers.

Journal: NPJ precision oncology
Published: October 17, 2025

Correction: Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment.

Correction: Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment.

Journal: Cancer research communications
Published: April 08, 2025

A potent phenylalkylamine disrupts mycobacterial membrane bioenergetics and augments bactericidal activity of bedaquiline.

A potent phenylalkylamine disrupts mycobacterial membrane bioenergetics and augments bactericidal activity of bedaquiline.

Journal: iScience
Published: January 06, 2025

Editorial: Mitochondrial plasticity and quality control in health and disease.

Editorial: Mitochondrial plasticity and quality control in health and disease.

Journal: Frontiers in cell and developmental biology
Published: July 22, 2024

Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance.

Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance.

Journal: Theranostics
Published: July 01, 2024

Advances in Non-Small Cell Lung Cancer (NSCLC) Treatment-A Paradigm Shift in Oncology.

Advances in Non-Small Cell Lung Cancer (NSCLC) Treatment-A Paradigm Shift in Oncology.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 02, 2024

Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment.

Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment.

Journal: Cancer research communications
Published: April 11, 2023

Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing.

Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 13, 2023

Effects of Leea indica leaf extracts and its phytoconstituents on natural killer cell-mediated cytotoxicity in human ovarian cancer.

Effects of Leea indica leaf extracts and its phytoconstituents on natural killer cell-mediated cytotoxicity in human ovarian cancer.

Journal: BMC complementary medicine and therapies
Published: November 17, 2022

Protein Lipidation by Palmitoylation and Myristoylation in Cancer.

Protein Lipidation by Palmitoylation and Myristoylation in Cancer.

Journal: Frontiers in cell and developmental biology
Published: February 28, 2021

Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention.

Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention.

Journal: Cancers
Published: February 19, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026